Fish oil supplement use is linked to a lower risk of severe fatty liver disease.
“Cystatin C is linked to metabolic disturbances and inflammation, both central to disease progression. Together, these pathways suggest that omega-3 fatty acids may lower severe NAFLD risk by simultaneously improving inflammation control, lipid handling, and metabolic balance.”